St. Jude Medical (STJ) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall St set for muted open as tech wobble persists; Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Vertiv shares fall on analyst downgrades and options bets
- European stocks rise, dollar set for weekly loss after yields drop
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
St. Jude Medical Reports Third Quarter 2016 Results
October 19, 2016 7:15 AM EDTST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today reported sales and net earnings for the third quarter ended October 1, 2016.
Third quarter 2016 highlights:
Net sales of $1.499 billion increased 12 percent as reported, or 2 percent on a comparable constant currency basis. International sales increased 13 percent as reported or 8 percent on a comparable constant currency basis, where a full portfolio of products is available. Neuromodulation sales increased 17 percent both as reported and on a constant currency... More


